Due to the fact that human MAPK3 is a common target for both obesity and DM, and is linked with the insulin signaling pathway, we report the virtual screening of the JME phytocompounds as novel potential inhibitors of human MAPK3 in this work. The gene discussed is MAPK3; the disease is obesity disorder.